S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Selective heart rate reduction with ivabradine unloads the left ventricle in.

Slides:



Advertisements
Similar presentations
Hover over a hexagon for more information
Advertisements

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Efficacy and safety of ivabradine in patients with chronic systolic heart failure.
CARDIAC OUTPUT Is commonly measured in patients with: Heart failure Shock Syndromes and after Coronary Artery Bypass Graft Surgery.
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Heart rate reduction with ivabradine and health related quality of life in.
analysis from the SHIFT study
May 23rd, 2012 Hot topics from the Heart Failure Congress in Belgrade.
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.
Effect of ivabradine on recurrent hospitalization for worsening heart failure: findings from SHIFT S ystolic H eart failure treatment with the I f inhibitor.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Blood Pressure Is measured in arteries where it is highest Is measured in arteries where it is highest Pressure decreases with distance from heart Pressure.
Blood Pressure. Blood pressure is the force exerted by the blood against the walls of the blood vessels. It is necessary to maintain blood flow though.
Effect of ivabradine on recurrent hospitalization for worsening heart failure: findings from SHIFT S ystolic H eart failure treatment with the I f inhibitor.
Target Study Cardiac resynchronization therapy (CRT) is an established treatment for advanced heart failure symptoms, impaired LV systolic function, and.
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Main results Swedberg K, et al. Lancet. 2010;376(9744):
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Efficacy and safety of ivabradine in patients with severe chronic systolic.
Frank-Starling Mechanism
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT Systolic Heart failure.
Camm J, et al. On Behalf of The SHIFT Gothenburg, Cardiac safety of selective heart rate reduction with Ivabradine in chronic heart failure. Poster, Heart.
S ystolic H eart failure treatment with the If inhibitor ivabradine T rial Michel Komajda and Karl Swedberg on behalf of the Investigators.
The Cardiac Cycle. The repeating pattern of contraction (systole) and relaxation (diastole) of the heart The repeating pattern of contraction (systole)
Blood and Blood Pressure. Components of Blood Plasma – Liquid portion of blood – Contains ions, proteins, hormones Cells – ___________________________________.
LESSON 12 – INTRODUCTION TO BLOOD PRESSURE AND CIRCULATORY SYSTEM.
The Cardiac Cycle. The repeating pattern of contraction (systole) and relaxation (diastole) of the heart The repeating pattern of contraction (systole)
The cardiac cycle Ventricular filling the diastole refers to the period of the cardiac cycle during which the ventricles are filling with blood the systole.
New 2011 SHIFT quality of life substudy Quality of life ( QoL) in heart failure: where do we stand? Therapies that have survival benefits either have a.
© 2015 Pearson Education, Inc. Figure Pressure and Volume Relationships in the Cardiac Cycle. Aorta Electro- cardiogram (ECG) QRS complex P T ONE.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Renal Denervation in Moderate Treatment-Resistant.
CARDIO-VASCULAR SYSTEM – Part 2 Jony Mallik B. Pharmacy; M. Pharmacy
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Rapid improvement of nitric oxide bioavailability.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Overview of the 2011 Food and Drug Administration.
 Describe the cardiac cycle (how the heart beats)  Understand the relationship with changing pressures and the valve closures.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pulmonary Arterial Hypertension J Am Coll Cardiol.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
Date of download: 11/13/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Reality of Heart Failure in Latin America J.
Management of mitral regurgitation. See legend for Fig
Cardiac Physiology Class 1.
Heart Rate Blood Pressure
B – The Cardiovascular System
Date of download: 1/13/2018 Copyright © ASME. All rights reserved.
Atorvastatin 20 mg (n=25 lesions) Atorvastatin 5 mg (n=25 lesions)
Creatinine clearance (mL/min) n All-cause mortality (%)
המצגת הוכנה על ידי צוות פיתוח הדרכת מתנדבים
Systolic Heart failure treatment with the If inhibitor ivabradine Trial The effect of heart rate reduction with ivabradine on renal function in patients.
המצגת הוכנה על ידי צוות פיתוח הדרכת מתנדבים
INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.
POSEIDON-DCM Trial design: Patients with nonischemic dilated cardiomyopathy were randomized to transendocardial injection of allogenic (n = 18) vs. autologous.
Median total new lesion volume
بعض مؤشرات القلب والدورة الدموية : معدل النبض ( ضربات القلب )
Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.
Acute Cardiovascular responses
Using Heart Rate as a Biomarker in Clinical Practice.
Mirnela Byku, and Douglas L. Mann BTS 2016;1:95-106
Blood Vessels and The Heart
Case #1 Case #1 (cont) Case #1 (cont)
Mirnela Byku, and Douglas L. Mann BTS 2016;1:95-106
Blood Flow Blood flow = Cardiac output (CO)= HR x SV
ß-blocker therapy for heart failure at the turn of the millennium
CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.
Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.
Baseline Characteristics by Baseline N-BNP Level
Connie W. Tsao et al. JCHF 2016;4:
Nat. Rev. Cardiol. doi: /nrcardio
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,
Within-group comparisons of adjusted mean±SEM of absolute change in peak systolic strain (%) from baseline to 12 months using the American Heart Association.
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Protocols used in Experiment 1.
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.
Presentation transcript:

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients JC, et al. J Am Coll Cardiol Nov 19;62(21):

Effect of HR reduction with ivabradine on stroke volume and cardiac output in patients with systolic HF Stroke volume, ml Cardiac output, ml/min P =0.31P <0.01 P < JC, et al. J Am Coll Cardiol Nov 19;62(21): Baseline Month 8 n=275 Procoralan maintains cardiac output. Procoralan increases stroke volume.

Ivabradine has no impact on blood pressure even in the long term JC, et al. J Am Coll Cardiol Nov 19;62(21): Baseline Month 8 Blood pressure (mmHg) NS n=275